ISO News

Eight IPOs joined the public market this past week, joined by ten SPACs. Two companies postponed, both citing market conditions: fitness equipment brand iFIT Health & Fitness (IFIT) and drug developer AEON Biopharma (AEON). New filers continued to flood the pipeline, with 22 IPOs and 12 SPACs submitting initial filings. Canada-listed...read more

IsoPlexis, which provides a single-cell proteomics platform for drug development, raised $125 million by offering 8.3 million shares at $15, the midpoint of the $14 to $16 range. At pricing, the company commands a fully diluted market value of $648 million. The Branford, CT-based company plans to list on the Nasdaq under the symbol ISO. Morgan Stanley, Cowen, Evercore ISI, and...read more

Updated Monday, 10/4. In the first full week of October, seven IPOs are slated to raise $2.0 billion, led by two fitness companies. Fitness chain Life Time Group Holdings (LTH) plans to raise $901 million at a $4.1 billion market cap. Taken private in 2015, Life Time operates more than 150 "centers" across 29 US states and one province in Canada,...read more

IsoPlexis, which provides a single-cell proteomics platform for drug development, announced terms for its IPO on Friday. The Branford, CT-based company plans to raise $125 million by offering 8.3 million shares at a price range of $14 to $16. At the midpoint of the proposed range, IsoPlexis would command a fully diluted market value of $648 million. IsoPlexis believes its...read more